Highly Active Antiretroviral Therapy Use and HIV Transmission Risk Behaviors Among Individuals Who Are HIV Infected and Were Recently Released From Jail

Clements-Nolle, Kristen; Marx, Rani; Pendo, Michael; Loughran, Eileen; Estes, Milton; Katz, Mitchell
April 2008
American Journal of Public Health;Apr2008, Vol. 98 Issue 4, p661
Academic Journal
We evaluated highly active antiretroviral therapy (HAART) use and risk behaviors among 177 inmates who were HIV infected and were released and reincarcerated in San Francisco, Calif, jails over a 12-month period. During the month preceding reincarceration, HIV transmission risk behaviors were common among respondents, and 59% of those with a history of antiretroviral use were not taking HAART. HAART discontinuation was independently associated with homelessness, marijuana use, injection drug use, and not receiving community medical care. Postrelease interventions for inmates who are HIV infected are needed. (Am J Public Health. 2008;98:661-666. doi:10.2105/AJPH.2007.112656)


Related Articles

  • Current perspectives in HIV post-exposure prophylaxis. Sultan, Binta; Benn, Paul; Waters, Laura // HIV/AIDS - Research & Palliative Care;2014, Vol. 6, p147 

    The incidence of human immunodeficiency virus (HIV) infection continues to rise among core groups and efforts to reduce the numbers of new infections are being redoubled. Post-exposure prophylaxis (PEP) is the use of short-term antiretroviral therapy (ART) to reduce the risk of acquisition of...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Early Use of Antiretrovirals May Reduce HIV Transmission. Norman, Kayda // Applied Clinical Trials;Jun2011, Vol. 20 Issue 6, p17 

    The article discusses the findings of a study on a clinical trial known as the HPTN 052 in relation to the early use of oral antiretroviral therapy (ART). It states that the early use of ART may reduce the likelihood that a person with human immunodeficiency virus (HIV) will pass the virus to...

  • Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods.  // BMC Public Health;2012, Vol. 12 Issue 1, p296 

    The article presents the findings of a research conducted on examining the risk of HIV transmission in a person on ART. It mentions that this PARTNER study is an international and observational study taking place from 2010 to 2014, in which HIV serodifferent partnerships who at enrolment...

  • Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings. Revell, A. D.; Wang, D.; Harrigan, R.; Hamers, R. L.; Wensing, A. M. J.; DeWolf, F.; Nelson, M.; Geretti, A.-M.; Larder, B. A. // Journal of Antimicrobial Chemotherapy (JAC);Apr2010, Vol. 65 Issue 4, p605 

    In the absence of widespread access to individualized laboratory monitoring, which forms an integral part of HIV patient management in resource-rich settings, the roll-out of highly active antiretroviral therapy (HAART) in resource-limited settings has adopted a public health approach based on...

  • Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). Torti, Carlo; Raffetti, Elena; Donato, Francesco; Castelli, Francesco; Maggiolo, Franco; Angarano, Gioacchino; Mazzotta, Francesco; Gori, Andrea; Sighinolfi, Laura; Pan, Angelo; Cauda, Roberto; Scalzini, Alfredo; Quiros-Roldan, Eugenia; Nasta, Paola; Gregis, Giampietro; Benatti, Simone; Digiambenedetto, Simona; Ladisa, Nicoletta; Giralda, Mariarosaria; Saracino, Annalisa // International Journal of Epidemiology;Apr2017, Vol. 46 Issue 2, p1 

    No abstract available.

  • Cost-effectiveness estimates for antenatal HIV testing in the Netherlands. Rozenbaum, M. H.; Verweel, G.; Folkerts, D. K. F.; Dronkers, F.; Van den Hoek, J. A. R.; Hartwig, N. G.; de Groot, R.; Postma, M. J. // International Journal of STD & AIDS;Oct2008, Vol. 19 Issue 10, p668 

    This paper provides an estimation of the lifetime health-care cost of HIV-infected children and an update of the costeffectiveness of universal HIV-screening of pregnant women in Amsterdam (The Netherlands). During 2003-2005, we collected data concerning the prevalence of newly diagnosed...

  • Antiretrovirals in Pregnancy: A Note of Caution. Watts, D. Heather; Mofenson, Lynne M. // Journal of Infectious Diseases;Dec2012, Vol. 206 Issue 11, p1639 

    The author discusses maternal-to-child transmission (MTCT) of human immunodeficiency virus (HIV). He is critical of the antenatal highly active antiretroviral therapy (HAART) for all women regardless of maternal CD4+ cell count. He reflects to the guidelines issued by the World Health...

  • Transmission of HIV-1 Drug-Resistant Variants: Prevalence and Effect on Treatment Outcome. Jakobsen, Martin R.; Tolstrup, Martin; Søgaard, Ole S.; Jørgensen, Louise B.; Gorry, Paul R.; Laursen, Alex; Østergaard, Lars // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, p566 

    Background. Human immunodeficiency virus type 1 (HIV-1) drug resistance is an important threat to the overall success of antiretroviral therapy (ART). Because of the limited sensitivity of commercial assays, transmitted drug resistance (TDR) may be underestimated; thus, the effect that TDR has...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics